Anteris Technologies Global Corp
AVR3.280USD
+0.210+6.84%
Market hours （ET）Quotes delayed by 15 min
118.28MMarket Cap
LossP/E TTM
More Details of Anteris Technologies Global Corp Company
Anteris Technologies Global Corp. is a structural heart company engaged in discovering, developing and commercializing medical devices designed to improve the quality of life for patients with aortic stenosis. It is engaged in the research and development of its biomimetic technology (ADAPT, DurAVR Transcatheter Heart Valve (THV), ComASUR Transfemoral Delivery System) to address unmet medical needs in the treatment of aortic stenosis. The DurAVR THV, with its single piece, native-shaped biomimetic design is built to mimic the performance of a healthy aortic valve and to restore normal laminar (smooth) blood flow. This class of technology can be used to treat new aortic stenosis patients and to treat aortic stenosis patients with failed valves (valve-in-valve). ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. ComASUR is its balloon-expandable delivery system.
Company Info
Ticker SymbolAVR
Company nameAnteris Technologies Global Corp
IPO dateDec 13, 2024
CEOMr. Wayne G. Paterson
Number of employees136
Security typeOrdinary Share
Fiscal year-endDec 13
Address860 Blue Gentian Road
CityEAGAN
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code55121
Phone16514930606
Websitehttps://anteristech.com/
Ticker SymbolAVR
IPO dateDec 13, 2024
CEOMr. Wayne G. Paterson
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. John Daniel Seaberg
Mr. John Daniel Seaberg
Independent Chairman of the Board
Independent Chairman of the Board
188.36K
--
Mr. Stephen Denaro
Mr. Stephen Denaro
Company Secretary, Non-Executive Director
Company Secretary, Non-Executive Director
23.72K
+228.47%
Mr. Wayne G. Paterson
Mr. Wayne G. Paterson
Chief Executive Officer, Vice Chairman of the Board
Chief Executive Officer, Vice Chairman of the Board
--
--
Mr. Matthew Mcdonnell
Mr. Matthew Mcdonnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
--
-100.00%
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Director
Director
--
--
Mr. David Brian (Dave) Roberts
Mr. David Brian (Dave) Roberts
Director
Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. John Daniel Seaberg
Mr. John Daniel Seaberg
Independent Chairman of the Board
Independent Chairman of the Board
188.36K
--
Mr. Stephen Denaro
Mr. Stephen Denaro
Company Secretary, Non-Executive Director
Company Secretary, Non-Executive Director
23.72K
+228.47%
Mr. Wayne G. Paterson
Mr. Wayne G. Paterson
Chief Executive Officer, Vice Chairman of the Board
Chief Executive Officer, Vice Chairman of the Board
--
--
Mr. Matthew Mcdonnell
Mr. Matthew Mcdonnell
Chief Financial Officer
Chief Financial Officer
--
--
Mr. David St Denis
Mr. David St Denis
President, Director
President, Director
--
-100.00%
Mr. Gregory S. Moss, Esq.
Mr. Gregory S. Moss, Esq.
Director
Director
--
--
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
FY2022
No Data
By RegionUSD
Name
Revenue
Proportion
United States
277.00K
49.82%
Germany
271.00K
48.74%
Australia
8.00K
1.44%
By Business
By Region
No Data
Shareholding Stats
Updated: Wed, Jul 2
Updated: Wed, Jul 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
L1 Capital Pty Ltd.
18.69%
Sio Capital Management, LLC
9.61%
Perceptive Advisors LLC
6.77%
Adar1 Capital Management LLC
4.65%
Nantahala Capital Management, LLC
4.61%
Other
55.67%
Shareholders
Shareholders
Proportion
L1 Capital Pty Ltd.
18.69%
Sio Capital Management, LLC
9.61%
Perceptive Advisors LLC
6.77%
Adar1 Capital Management LLC
4.65%
Nantahala Capital Management, LLC
4.61%
Other
55.67%
Shareholder Types
Shareholders
Proportion
Investment Advisor
28.16%
Hedge Fund
26.44%
Private Equity
6.77%
Investment Advisor/Hedge Fund
2.13%
Research Firm
0.57%
Individual Investor
0.21%
Bank and Trust
0.04%
Pension Fund
0.02%
Other
35.66%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
91
24.62M
68.26%
+3.93M
2025Q1
90
23.52M
65.25%
+5.92M
2024Q4
34
19.02M
52.80%
+19.02M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
L1 Capital Pty Ltd.
6.74M
18.69%
-145.08K
-2.11%
Apr 14, 2025
Sio Capital Management, LLC
3.46M
9.61%
+1.10M
+46.20%
Apr 14, 2025
Perceptive Advisors LLC
2.44M
6.77%
+300.00K
+14.02%
Apr 14, 2025
Adar1 Capital Management LLC
1.68M
4.65%
+625.10K
+59.37%
Mar 31, 2025
Nantahala Capital Management, LLC
1.66M
4.61%
-3.00K
-0.18%
Mar 31, 2025
Ensign Peak Advisors, Inc.
1.44M
4%
+401.32K
+38.61%
Mar 31, 2025
Rhenman & Partners Asset Management AB
1.29M
3.58%
+1.29M
--
Mar 31, 2025
Regal Partners Limited
896.16K
2.49%
-397.70K
-30.74%
Mar 31, 2025
Alyeska Investment Group, L.P.
550.00K
1.53%
--
--
Mar 31, 2025
Affinity Asset Advisors LLC
390.00K
1.08%
+90.00K
+30.00%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
iShares Micro-Cap ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Value ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proportion0.02%
iShares Russell 2000 Growth ETF
Proportion0.01%
Global X Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
